Anxiety News and Research

Latest Anxiety News and Research

NARSAD honours UNC's Patrick Sullivan with 2010 Distinguished Investigator Award

Patrick Sullivan, MD has received a 2010 Distinguished Investigator Award from NARSAD for a comparison of genetics in schizophrenia and bipolar disorder.

13 May 2010

With campaign season taking off, White House offers Democrats help on selling health law

White House officials prepared a plan Tuesday to help Democrats sell the health reform law during the midterm election season that will focus on early deliverables to win over a skeptical public.

13 May 2010

Art therapy benefits children with persistent asthma: Researchers

In the first randomized trial of art therapy for asthma, National Jewish Health researchers found that children with persistent asthma enjoyed decreased anxiety and increased quality of life after seven weekly art-therapy sessions.

13 May 2010

Regular exercise plays important role in improving wellbeing of patients with schizophrenia: Review

Regular exercise can play an important a role in improving the physical and mental wellbeing of individuals with schizophrenia, according to a review published in The Cochrane Library.

12 May 2010

Overtime workers at 60% higher risk of heart-related problems

Working overtime is bad for the heart according to results from a long-running study following more than 10,000 civil servants in London (UK): the Whitehall II study.

11 May 2010

Older Americans staying sexually active but not practicing safe sex

Sexual activity continues to thrive with the 45+ demographic according to a new AARP sex survey, Sex, Romance, and Relationships: AARP Survey of Midlife and Older Adults, released today. However, older adults are not necessarily practicing what they preach to younger generations, with results showing a low use of protection among sexually active dating singles with only one in five reporting use of condoms regularly.

11 May 2010

Study reveals association between cardiac vagal activity and functional somatic symptoms

A study in the current issue of Psychotherapy and Psychosomatics outlines some novel insights between cardiac vagal activity [heart rate variability in the high-frequency band (HRV-HF)] and symptoms that do not find an organic explanation.

11 May 2010

MediciNova announces $15 million senior secured term loan with Oxford Finance

MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today announced that it has entered into a $15 million senior secured term loan with Oxford Finance Corporation.

11 May 2010

CINJ nurses to present at Oncology Nursing Society's 35th Annual Congress

Florence Nightingale once stated that nursing is an art that requires as much devotion and preparation as any painting or sculpture. This sentiment is echoed in the work of today's nurses and their pursuit of both clinical knowledge and technical expertise. Nurses from The Cancer Institute of New Jersey (CINJ) and throughout the country, will be doing their part in contributing to the art of nursing when presenting at the Oncology Nursing Society's 35th Annual Congress being held this week in San Diego, California.

11 May 2010

Forest, Nycomed to present data from six roflumilast posters at ATS International Conference

Forest Laboratories, Inc. and Nycomed today announced that they will present data from six roflumilast posters during the American Thoracic Society (ATS) International Conference being held in New Orleans, LA, May 14 through May 19, 2010. Roflumilast is an investigational anti-inflammatory, oral medication for the treatment of Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis in patients at risk of exacerbations.

10 May 2010

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced that Takeda has entered into a co-promotion agreement with Janssen Pharmaceutical K.K. for VELCADE® (bortezomib) for Injection, a treatment for patients with multiple myeloma.

10 May 2010

President says health reform already delivering 'real benefits'

The Associated Press: "The new health care law already is helping millions of people through tax breaks for small businesses and assistance for families with young adults, President Barack Obama said Saturday" (Babington, 5/8).

10 May 2010

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.

7 May 2010

New changes to 'Extra Help' program enables more people save on prescription drug costs

Medicare beneficiaries who qualify for "Extra Help" may be eligible to pay no more than $2.50 for generic drugs and $6.30 for each brand name drug thanks to changes to Medicare's Low-Income Subsidy Program for Part D prescription drug costs (also known as LIS or "Extra Help") that take effect this year. These changes make it easier than ever for people on Medicare with limited incomes to save on their drug costs.

7 May 2010

M-3 Information introduces iPhone application for depression, anxiety disorders

M-3 Information entered the smart phone application environment by offering the M-3 Checklist, a scientifically validated screen for depression and anxiety disorders, at the iTunes store on Friday, April 30, 2010. Adapted from M-3 Information's existing mymoodmonitor.com website, this mobile version, called mym3, provides the same validated mental health questionnaire optimized for smart phones. A first in iPhone applications, mym3 is designed to create a bridge between user responses and recommendations set forth in the content-rich M3 website application.

7 May 2010

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

DUSA Pharmaceuticals, Inc.®, a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U®, Blue Light Photodynamic Therapy Illuminator.

7 May 2010

Neuroscientists investigate alcohol dependency, withdrawal in C. elegans worms

Drinking alcohol over a long period of time profoundly affects the brain, which adapts to the intoxicant and causes withdrawal symptoms when consumption stops.

6 May 2010

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Labopharm Inc. today reported its financial results for the first quarter 2010.

6 May 2010

Polls show slowly shifting opinion on health law

USA Today: "Fifty-five percent of Americans rate the nation's health care system as good or excellent, compared with 44% in February and 35% when President Obama first proposed his health care legislation, according to a poll released today by Rasmussen Reports." USA Today notes that even though many of the changes are not going to be implemented until 2014, many insurance companies are voluntarily changing some practices early (Fritze, 5/3).

5 May 2010

Widespread support for a full flu vaccine side effects enquiry

After nearly 250 children suffered from serious side effects of the seasonal flu shots including one death the Western Australian Government’s step to suspend further vaccinations and investigate the issue has received widespread support. The enquiry will look into the Health Department's handling of the flu vaccination program as well.

4 May 2010

Anxiety News and Research

Latest Anxiety News and Research

NARSAD honours UNC's Patrick Sullivan with 2010 Distinguished Investigator Award

With campaign season taking off, White House offers Democrats help on selling health law

Art therapy benefits children with persistent asthma: Researchers

Regular exercise plays important role in improving wellbeing of patients with schizophrenia: Review

Overtime workers at 60% higher risk of heart-related problems

Older Americans staying sexually active but not practicing safe sex

Study reveals association between cardiac vagal activity and functional somatic symptoms

MediciNova announces $15 million senior secured term loan with Oxford Finance

CINJ nurses to present at Oncology Nursing Society's 35th Annual Congress

Forest, Nycomed to present data from six roflumilast posters at ATS International Conference

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

President says health reform already delivering 'real benefits'

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

New changes to 'Extra Help' program enables more people save on prescription drug costs

M-3 Information introduces iPhone application for depression, anxiety disorders

DUSA Pharmaceuticals receives notice of allowance for patent covering blue light technology

Neuroscientists investigate alcohol dependency, withdrawal in C. elegans worms

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Polls show slowly shifting opinion on health law

Widespread support for a full flu vaccine side effects enquiry

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Anxiety News and Research

Latest Anxiety News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in